At Darst Dermatology in Charlotte, NC we are currently recruiting individual as research participants.

Atopic Dermatitis Clinical Study:

Vanda VP-VLY-686-3101- A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, EFFICACY STUDY OF THE NEUROKININ-1 RECEPTOR ANTAGONIST VLY-686 IN PATIENTS WITH ATOPIC DERMATITIS. Enrollment open

A Randomized, Double-Blind, Placebo-Controlled Efficacy Study of The Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis

Inclusion Criteria:

• Male and non-pregnant, non-lactating female patients aged 18 – 70 years (inclusive);
• Diagnosed with atopic dermatitis;
• Suffering from chronic pruritus;
• Body Mass Index (BMI) of ≥18 and ≤40 kg/m2

Exclusion Criteria:

• Chronic pruritus due to condition other than atopic dermatitis (AD);
• A positive test for drugs of abuse at the screening or evaluation visits;
• Exposure to any investigational medication in the past 60 days

For more information, visit clinicaltrials.gov

If interested in participating in a clinical trial at Darst Dermatology, email us at [email protected]